WRBY

WARBY PARKER INC

WRBY·93403J106·US·Common Stock·Healthcare - Medical Instruments & Supplies-13D/G

WRBY (WARBY PARKER INC) is held by 154 institutional investors as of Q1 2026. Largest holders: FMR LLC ($327.1M), JPMORGAN CHASE & CO ($205.2M), BlackRock, Inc. ($152.9M). Net institutional sentiment: Mixed.

154
Holders
(18 Elite)
$2B
Total Value
56% (162)
Consensus
90 buying - 72 selling
13F: Insider & Congress:
WRBYSmart Money Verdict
View all
Held by 154 funds
18 elite
Who's Trading
ActivistBlackRock, Inc.BlackRock, Inc.14.0%Jul 8, 2026
InsiderGAGilboa David AbrahamSell $1.6MJul 6, 2026
InsiderBHBlumenthal Neil HarrisSell $276KJul 6, 2026
ActivistJPMORGAN CHASE & COJPMORGAN CHASE & CO10.2%Jun 4, 2026
ActivistVPVanguard Portfolio Management5.1%Apr 29, 2026
InsiderBHBlumenthal Neil HarrisSell $563KApr 20, 2026
InsiderBHBlumenthal Neil HarrisSell $690KApr 17, 2026
InsiderBHBlumenthal Neil HarrisSell $1.2MApr 17, 2026
InsiderBHBlumenthal Neil HarrisSell $56KApr 16, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
15.5M(+1.0%)$327.1M0.0%+24.87%
31
Increased
10.1M(+4.2%)$205.2M0.0%+23.75%
32
Decreased
7.3M(-9.0%)$152.9M0.0%+19.79%
0
Decreased
6.4M(-12.5%)$134.8M1.4%-3.02%
0
New
5.3M$112.3M0.0%+5.71%
42
New
4.4M$92.8M0.0%+5.71%
41
Increased
3M(+31.3%)$63.8M0.6%+36.06%
53
Increased
2.4M(+0.6%)$51.1M0.0%+90.20%
29
Increased
2.4M(+3.4%)$50M0.0%+77.52%
30
Increased
2.3M(+8.4%)$48.7M0.2%+29.43%
38
Decreased
1.8M(-13.9%)$37M0.0%+41.10%
0
Increased
1.7M(+10.7%)$36.3M0.0%+77.05%
32
Decreased
1.6M(-12.4%)$34M0.1%+31.93%
0
Decreased
1.5M(-41.3%)$32.1M0.0%+52.46%
0
Decreased
1.5M(-28.4%)$31.4M0.0%+16.16%
0
Increased
1.4M(+0.3%)$30.3M0.3%+31.83%
35
Increased
1.4M(+30.9%)$29M0.0%+24.67%
36
New
1.4M$28.7M0.0%+5.71%
40
Increased
1.3M(+22.2%)$28.3M0.0%+26.83%
35
Decreased
1.3M(-6.0%)$27.3M0.0%+35.09%
0

Showing 1-20 of 169

1 / 9

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used